Optibiotix Health Share Discussion Threads

[talkingtrade] 03/5/2017 09:46

Not looking good here.Could see 60p or lower.AIMHO

[bobdown2] 03/5/2017 09:38

Typical aim, short term investors, funding and mm,s. You need to get past all three even when you have researched a great company. We have a company on the cusp of its revenues and the products are being validated by the large companies that are taking up its products. There are new products with great health benefits just around the corner and there is selling. Probably indiscrimate selling of an initial funding that is causing the fear that makes investors sell. Aim.!!! The mind boggles.

[primal123] 03/5/2017 09:30

Very disappointing to be back in the 60s. I hope the launch of the LDL-LP next week changes the trend.

[judijudi] 03/5/2017 09:18

Sbtx getting a reet good kick along alongside us

[marnewton] 03/5/2017 08:44

It's certainly touch-and-go, bob.

Investors holding their nerve whilst awaiting new news!

M

[bobdown2] 03/5/2017 08:28

I might be that some of the 10k trades are being matched to the background buyer and the buy shown later. Just a thought!!

[judijudi] 03/5/2017 08:26

10k seller around
Another drip down day mee thinks

[bobdown2] 03/5/2017 08:14

Thanks marnewton hopefully the 10 k seller will not take us through the bottom of this range and a higher high will be up in the 90 pence area. The recent and upcoming news would suggest that this is where the share price should be !!

[elrico] 03/5/2017 08:08

This creates the potential for next generation LP(LDL)(R) products with cholesterol reduction levels potentially approaching those of statins.

Possibly the only significant item in the RNS. The point being, this is really about building brand awareness to key decision makers in the pre-probiotic ingredient markets. Whilst this approach may seem complex having a number of platforms creating multiple opportunities substantially de-risks the company. It’s a bit like having the Apple operating system being used in multiple products (Ipad, Iphone, Mac), you have multiple opportunities to succeed.

[marnewton] 03/5/2017 08:00

Still riding the lower trendline of the ascending channel - no closes below.

Positive divergence on stochastic.

M


Log scale daily candlestick chart:

[owenmo] 03/5/2017 07:56

And do I know all about mood swings Judi! With you 100%

[bobdown2] 03/5/2017 07:55

For those watching the buying and selling . A 49k buy after hours showing this morning. The other trades look to be a bed and breakfast and another that is nothing of relevance. Will the buying increase now that the product news is increasing. And will it be enough to clear out the 10k merchant!!

[judijudi] 03/5/2017 07:52

Owen,
It's never left me
Still Sanguine (ish)
A falling share price naturally causes angst (no matter what anybody else may say) whereas a rising one causes comfort (as we all know)
Just purely a normal human reaction to a few very poor weeks share price wise
And unless buyers start to outnumber sellers, that ain't going to change

[owenmo] 03/5/2017 07:47

Sanquinity restored Judi?

[owenmo] 03/5/2017 07:42

The difference in Budapest of course is that Opti products will have presented to the market; the proof of the pudding will be in the offing; a major advancement.

[owenmo] 03/5/2017 07:38

Yes Parob - however Opti share price and RNSs in recent times demonstrate a dysfunctional relationship. Will May 3rd. be any different? But I share your view that it's a matter of time.

[parob] 03/5/2017 07:21

This creates the potential for next generation LP(LDL) (R) products with cholesterol reduction levels potentially approaching those of statins.And there we have it, in an official RNS. It's just a matter of time.The Berlin conference attracted many companies to OPTI and so will this one in Budapest.

[someuwin] 03/5/2017 07:04

OptiBiotix Health plc

("OptiBiotix" or the "Company")

Presentation of abstract at Probiotics and Prebiotics conference

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has had an abstract accepted for presentation at the International Scientific Conference on Probiotics and Prebiotics in Budapest, Hungary from 20 - 22 June 2017 (IPC2017). IPC2017 is the largest scientific conference worldwide focusing on probiotics and prebiotics for scientists, researchers, product developers, industry and the investment community. The conference attracts up to 500 leading scientists, opinion leaders, investors, and clinicians from more than 80 countries.

The abstract, titled "The Development of a Targeted Synergistic Synbiotic for Lactobacillus plantarum LPLDL®", describes how by combining its OptiScreen® and OptiBiotic®, OptiBiotix were able to synthesise a dietary fibre that substantially enhances the cholesterol reducing activity of LPLDL® in gut models. This creates the potential for next generation LPLDL® products with cholesterol reduction levels potentially approaching those of statins.

Commenting, Stephen O'Hara, CEO of OptiBiotix said: "This abstract demonstrates the ability of OptiBiotix to create targeted prebiotics which when combined with a probiotic greatly enhances the probiotics growth and biological effect, in this case cholesterol reduction. This new research highlights the potential for the development of species or genera-specific probiotics to selectively enhance the growth and health benefits of existing probiotics. This has the potential to provide improved next generation products with enhanced performance and product differentiation in the probiotics functional food market, a market that is expected to be worth in excess of $46.5bn by 2020."

[monkeywench1] 02/5/2017 22:15

I meant the idiot rampers. They are easy to spot..even for novices.